Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01729416
Other study ID # 297959
Secondary ID 297959-4
Status Completed
Phase N/A
First received November 2, 2012
Last updated May 26, 2017
Start date February 2014
Est. completion date April 2015

Study information

Verified date May 2017
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if screening colonoscopy performed on adults with the water exchange method, as opposed to the air method, will have a higher adenoma detection rate.


Description:

Screening colonoscopy with removal of pre-cancerous adenomas was recently shown to result in a 53% reduction in mortality from colon cancer. While this clearly validates the practice of screening colonoscopy, missed adenomas, especially in the proximal colon, defined as including cecum, ascending colon, and transverse colon, remains a concern. This was demonstrated in a study of 183 patients who underwent back-to-back colonoscopies. In this population the overall miss rate for adenomas was 24% with proximal adenomas missed more often (27%) than left colon adenomas (21%). Another study looked at 4192 patients in the SEER (Surveillance, Epidemiology, and End Results) Medicare database who developed "interval cancers", that is colon cancer in a patient who had a colonoscopy done in the previous 6-36 months. These interval cancers were predominantly in the proximal colon (Proximal 68%, Distal 19.5%, rectum 10.4%, and unspecified 2.1%). This also suggests that pre-cancerous lesions are being missed in the proximal colon. As such a method that can increase proximal adenoma detection rate would be a welcome change.

One such emerging technique which shows promise for improving adenoma detection rate is water colonoscopy. In one of the early studies employing the water method a trend towards a higher ADR in the water method group was recognized (37% vs. 26%). The observation prompted a retrospective analysis of 1178 cases of screening and surveillance colonoscopy performed by a single endoscopist at the Sacramento VAMC, which showed an overall ADR (presence of at least one adenoma) of 27% with air colonoscopy whereas that for the water method colonoscopy was 35% (p=0.007). In a subsequent combined analysis of two prospective RCT of air vs. water colonoscopy for screening and surveillance using scheduled unsedated colonoscopy [5] and on-demand sedation [6], more patients were found to have at least one diminutive adenoma in the proximal colon in the water method group than in the air group (28% vs. 14%, respectively, p=0.0298). Another quasi randomized study of screening patients performed at Phoenix VAMC using high definition equipment confirmed a significantly higher overall ADR with the water method (n=177) compared with the air method (n=191) (57% vs. 46%) (p=0.03). The odds of detecting an adenoma was 81% higher with the water method (OR 1.81; 95% CI: 1.12-2.90) and independent of age, body mass index (BMI), current smoking and alcohol use, withdrawal time & quality of bowel preparation. In the proximal colon ADR was significantly higher in patients examined with the water method than with air method (46% vs. 35%) (p=0.03), particularly for adenomas <10 mm in size (38% vs. 25%) (p=007). These encouraging preliminary data reflect the potential benefits of water method colonoscopy.

Our current research question is whether this benefit is seen in a community based population as opposed to the VA population which is mostly male and Caucasian.

The investigators plan to perform a prospective, randomized controlled trial comparing proximal adenoma detection rate between a water exchange colonoscopy group and an air colonoscopy group. The investigators intend to employ scheduled sedation, instead of on-demand sedation, to continue the current protocol in place at our institution.

Patients in both the study arms will undergo a split bowel preparation before colonoscopy.


Recruitment information / eligibility

Status Completed
Enrollment 178
Est. completion date April 2015
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria:

- Age =50 years

- Individuals able to provide informed consent

- Individuals presenting for average-risk colorectal cancer screening by colonoscopy

- Individuals presenting for surveillance of adenomatous/sessile serrated colon polyps as per the US multi-society taskforce on colorectal cancer

Exclusion Criteria:

- Patients who decline to participate

- Prior partial or complete colectomy

- Patients with history of inflammatory bowel disease (ulcerative colitis or Crohn's disease)

- Patients with prior history of colorectal cancer

- Patients with history of screening colonoscopy within the past 10 years

- Patients with history of familial polyposis syndromes (Familial Adenomatous Polyposis, Lynch Syndrome)

Study Design


Intervention

Other:
Water Exchange Colonoscopy
We will turn off the air pump. The colonoscope will be inserted into the rectum and gently advanced. We will suction air pockets as scope is advanced towards the cecum. Water will be infused when encountering closed up lumen. All the infused water will be suctioned out. We will use all other techniques used with conventional air method as needed. For example abdominal pressure, shortening of scope to reduce looping, change of patient position etc. We will turn on air pump once cecum reached, or if unsuccessful with water method to open up a close lumen or to go past a tight turn. On withdrawal we will continue air insufflation as needed, and closely examine for polyps and remove all visualized polyps. If there is any residual fluid, it will be suctioned out as the scope is withdrawn.
Air Colonoscopy
Air will be infused into the colon during colonoscopy.

Locations

Country Name City State
United States Elk Grove PCN, University of California, Davis Elk Grove California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

References & Publications (9)

Lai EJ, Calderwood AH, Doros G, Fix OK, Jacobson BC. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009 Mar;69(3 Pt 2):620-5. doi: 10.1016/j.gie.2008.05.057. Epub 2009 Jan 10. — View Citation

Leung FW, Aharonian HS, Leung JW, Guth PH, Jackson G. Impact of a novel water method on scheduled unsedated colonoscopy in U.S. veterans. Gastrointest Endosc. 2009 Mar;69(3 Pt 1):546-50. doi: 10.1016/j.gie.2008.08.014. — View Citation

Leung FW, Harker JO, Jackson G, Okamoto KE, Behbahani OM, Jamgotchian NJ, Aharonian HS, Guth PH, Mann SK, Leung JW. A proof-of-principle, prospective, randomized, controlled trial demonstrating improved outcomes in scheduled unsedated colonoscopy by the water method. Gastrointest Endosc. 2010 Oct;72(4):693-700. doi: 10.1016/j.gie.2010.05.020. Epub 2010 Jul 8. — View Citation

Leung FW, Leung JW, Siao-Salera RM, Mann SK. The water method significantly enhances proximal diminutive adenoma detection rate in unsedated patients. J Interv Gastroenterol. 2011 Jan;1(1):8-13. — View Citation

Leung J, Mann S, Siao-Salera R, Ransibrahmanakul K, Lim B, Canete W, Samson L, Gutierrez R, Leung FW. A randomized, controlled trial to confirm the beneficial effects of the water method on U.S. veterans undergoing colonoscopy with the option of on-demand sedation. Gastrointest Endosc. 2011 Jan;73(1):103-10. doi: 10.1016/j.gie.2010.09.020. — View Citation

Leung JW, Do LD, Siao-Salera RM, Ngo C, Parikh DA, Mann SK, Leung FW. Retrospective analysis showing the water method increased adenoma detection rate - a hypothesis generating observation. J Interv Gastroenterol. 2011 Jan;1(1):3-7. — View Citation

Ramirez FC, Leung FW. A head-to-head comparison of the water vs. air method in patients undergoing screening colonoscopy. J Interv Gastroenterol. 2011 Jul;1(3):130-135. Epub 2011 Jul 1. — View Citation

Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, Lehman GA, Mark DG. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997 Jan;112(1):24-8. — View Citation

Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012 Feb 23;366(8):687-96. doi: 10.1056/NEJMoa1100370. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Proximal Adenoma detection Presence of adenoma detected anywhere between the cecum and the splenic flexure Data collected when pathology is available, typically 3-10 days after the patient's procedure. Data is collected only once per patient.
Secondary Total adenoma detection Adenoma detection anywhere in the colon during colonoscopy. Data collected when pathology is available, typically 3-10 days after the patient's procedure. Data is only collected once per patient.
Secondary Sedation requirements The amount of sedation required to complete the patient's colonoscopy. This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length.
Secondary Total procedure time The total time it takes to complete colonoscopy. This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length.
Secondary Cecal intubation time The time it takes to reach the cecum during colonoscopy. This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length.
Secondary Patient position change during procedure The need for patient's position to be changed from left lateral to other positions, to enable advancement of the colonoscope forward. This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length.
Secondary Use of colonoscope stiffener during procedure The need to stiffen the colonoscope to enable to forward movement of the scope during procedure This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length.
Secondary Abdominal pressure by assistant during procedure Need for abdominal pressure by endoscopist's assistant during procedure to enable forward movement of colonoscope. This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length.
Secondary Length of colonoscope at time of cecal intubation Assessment of length of the colonoscope inserted into the colon to reach the cecum. This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length.
Secondary Procedure-related pain score Assessment of discomfort due to the procedure, as possible during procedure, and post procedure after recovery from sedation, being cognizant of limitations posed by sedation and attendant amnesia. Data collected during and post procedure after recovery from sedation, which is usually within 1 hour post procedure
Secondary Reason for air insufflation, and length of colon when air insufflation started, while performing water colonoscopy Assessment of percentage of patient requiring air insufflation when water colon fails to open colonic lumen, and site of colon where this is most likely to happen. This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length.
Secondary Volume of water used during water colonoscopy Assessment of volume of water introduced into the colon during procedure. This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length.
Secondary Patient perception regarding air and water colonoscopy Assessment of patient's perception about the 2 methods of colonoscopy. This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length.
Secondary Advanced adenoma detection rate Data collected when pathology is available, typically 3-10 days after the patient's procedure. Data is only collected once per patient
Secondary Type of polypectomy (cold biopsy/cold snare/snare cautery/need for submucosal injection/need for clip placement) This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length
Secondary Bowel preparation quality by Boston Bowel Prep Scale This will be collected at the time of their procedure appointment which is expected to be 2 to 3 hours in length
Secondary Post procedure recovery time This will be collected at the time of their procedure appointment which is expected to be 2 to 3 hours in length
Secondary Serrated polyp detection rate This will be collected at the time of their procedure appointment which is expected to be 2 to 3 hours in length
Secondary Procedure time- morning versus afternoon This will be collected at the time of their procedure appointment which is expected to be 2 to 3 hours in length
Secondary Body Mass Index (BMI) This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length
Secondary Smoking history This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length
Secondary Alcohol consumption This will be collected at their procedure appointment which is expected to be 2 to 3 hours in length
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT03457454 - Reducing Rural Colon Cancer Disparities
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Completed NCT03390907 - Hybrid APC Assisted EMR for Large Colon Polyps N/A
Recruiting NCT03175224 - APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors Phase 2
Completed NCT04079478 - The AID Study: Artificial Intelligence for Colorectal Adenoma Detection
Active, not recruiting NCT04057274 - Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth N/A
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Not yet recruiting NCT05147545 - Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects N/A
Recruiting NCT05026268 - The Laparoscopic Right Colectomy With Intracoroporeal Anastomosis N/A
Not yet recruiting NCT03277235 - Effect of a Resilience Model-Based Care Plan in Newly Diagnosed Colorectal Cancer Patients N/A
Active, not recruiting NCT02730702 - Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure
Active, not recruiting NCT02959541 - PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer N/A
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A
Recruiting NCT02577627 - Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC N/A
Terminated NCT02628535 - Safety Study of MGD009 in B7-H3-expressing Tumors Phase 1
Recruiting NCT02526836 - Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer Phase 2/Phase 3